NeuroPace, Inc. (NPCE) Social Stream
NEUROPACE INC (NPCE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NEUROPACE INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-28 | 5 | $30 | $24 | $26.4 | $10.31 | 156.06% |
| 2021-11-11 | 5 | $30 | $17 | $25 | $10.31 | 142.48% |
| 2022-01-07 | 5 | $30 | $12 | $23.4 | $10.31 | 126.96% |
| 2022-02-01 | 5 | $26 | $11 | $17.6 | $10.31 | 70.71% |
| 2022-03-17 | 5 | $26 | $9 | $14.6 | $10.31 | 41.61% |
| 2022-05-13 | 4 | $26 | $6 | $14.2 | $10.31 | 37.73% |
| 2022-08-12 | 4 | $26 | $5.5 | $14.1 | $10.31 | 36.76% |
| 2022-11-09 | 3 | $13 | $3.5 | $9.875 | $10.31 | -4.22% |
| 2022-12-05 | 3 | $13 | $3.5 | $8.875 | $10.31 | -13.92% |
| 2022-12-13 | 3 | $13 | $3.5 | $8.375 | $10.31 | -18.77% |
| 2023-01-06 | 3 | $13 | $2.5 | $8.125 | $10.31 | -21.19% |
| 2023-02-22 | 3 | $13 | $2.5 | $7.875 | $10.31 | -23.62% |
| 2023-03-03 | 3 | $13 | $4.5 | $8.375 | $10.31 | -18.77% |
| 2023-08-09 | 3 | $10 | $5 | $7 | $10.31 | -32.1% |
| 2023-08-24 | 3 | $10 | $6 | $7.333 | $10.31 | -28.87% |
| 2023-10-04 | 4 | $10 | $6 | $7.75 | $10.31 | -24.83% |
| 2023-11-07 | 4 | $10 | $6 | $8.5 | $10.31 | -17.56% |
| 2023-11-29 | 5 | $11 | $8 | $9.4 | $10.31 | -8.83% |
| 2023-12-04 | 5 | $12 | $9 | $10 | $10.31 | -3.01% |
The Trend in the Analyst Price Target
Over the past 41 weeks, NPCE's average price target has gone up $2.12.
Over the past 47 weeks, NPCE's average upside potential has been 103.14%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-06 | 2 | 13 | 2.5 | 7.166 | 1.58 | 353.54% |
| 2023-03-03 | 3 | 13 | 4.5 | 8.375 | 4.10 | 104.27% |
| 2023-08-24 | 4 | 10 | 6.0 | 7.333 | 5.16 | 42.11% |
| 2023-11-29 | 5 | 11 | 8.0 | 9.400 | 8.74 | 7.55% |
| 2023-12-04 | 5 | 12 | 9.0 | 10.000 | 8.13 | 23% |
NPCE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 3 | 0 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 39 weeks, NPCE's average broker recommendation rating improved by 0.53.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NPCE as an investment opportunity.
- NEUROPACE INC's number of analysts covering the stock is higher than 421.06% of all US stocks.
- NEUROPACE INC's average analyst price target is greater than 421.48% of all US stocks.
- In terms of how NEUROPACE INC fares relative to Medical Equipment stocks, note that its variance in analysts' estimates is lower than -2357.35% of that group.
- In the context of stocks in the small market cap category, NEUROPACE INC's upside potential (average analyst target price relative to current price) is higher than 668% of them.
Stocks similar to NEUROPACE INC in the Medical Equipment industry regarding analyst recommendations and price targets are TMCI, SGHT, and PRCT.
View All Top Stocks by Price Target
What is the outlook for NPCE? Use POWR Ratings for clearer insight into price direction.